{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T08:13:57Z","timestamp":1791274437447,"version":"4.1.0"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2007,4,1]],"date-time":"2007-04-01T00:00:00Z","timestamp":1175385600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Nat Med"],"published-print":{"date-parts":[[2007,4]]},"DOI":"10.1038\/nm1561","type":"journal-article","created":{"date-parts":[[2007,4,1]],"date-time":"2007-04-01T17:31:49Z","timestamp":1175448709000},"page":"492-497","source":"Crossref","is-referenced-by-count":320,"title":["Direct suppression of CNS autoimmune inflammation via the cannabinoid receptor CB1 on neurons and CB2 on autoreactive T cells"],"prefix":"10.1038","volume":"13","author":[{"given":"Katarzyna","family":"Maresz","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gareth","family":"Pryce","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eugene D","family":"Ponomarev","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giovanni","family":"Marsicano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J Ludovic","family":"Croxford","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leah P","family":"Shriver","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catherine","family":"Ledent","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaodong","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erica J","family":"Carrier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Monica K","family":"Mann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gavin","family":"Giovannoni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roger G","family":"Pertwee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takashi","family":"Yamamura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nancy E","family":"Buckley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cecilia J","family":"Hillard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Beat","family":"Lutz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Baker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bonnie N","family":"Dittel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2007,4,1]]},"reference":[{"key":"BFnm1561_CR1","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1002\/jnr.490280213","volume":"28","author":"WF Hickey","year":"1991","unstructured":"Hickey, W.F., Hsu, B.L. & Kimura, H. T-lymphocyte entry into the central nervous system. J. Neurosci. Res. 28, 254\u2013260 (1991).","journal-title":"J. Neurosci. Res."},{"key":"BFnm1561_CR2","doi-asserted-by":"publisher","first-page":"683","DOI":"10.1146\/annurev.immunol.23.021704.115707","volume":"23","author":"M Sospedra","year":"2005","unstructured":"Sospedra, M. & Martin, R. Immunology of multiple sclerosis. Annu. Rev. Immunol. 23, 683\u2013747 (2005).","journal-title":"Annu. Rev. Immunol."},{"key":"BFnm1561_CR3","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1038\/346561a0","volume":"346","author":"LA Matsuda","year":"1990","unstructured":"Matsuda, L.A., Lolait, S.J., Brownstein, M.J., Young, A.C. & Bonner, T.I. Structure of a cannabinoid receptor and functional expression of the cloned cDNA. Nature 346, 561\u2013564 (1990).","journal-title":"Nature"},{"key":"BFnm1561_CR4","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1038\/365061a0","volume":"365","author":"S Munro","year":"1993","unstructured":"Munro, S., Thomas, K.L. & Abu-Shaar, M. Molecular characterization of a peripheral receptor for cannabinoids. Nature 365, 61\u201365 (1993).","journal-title":"Nature"},{"key":"BFnm1561_CR5","first-page":"736","volume":"42","author":"NE Kaminski","year":"1992","unstructured":"Kaminski, N.E., Abood, M.E., Kessler, F.K., Martin, B.R. & Schatz, A.R. Identification of a functionally relevant cannabinoid receptor on mouse spleen cells that is involved in cannabinoid-mediated immune modulation. Mol. Pharmacol. 42, 736\u2013742 (1992).","journal-title":"Mol. Pharmacol."},{"key":"BFnm1561_CR6","doi-asserted-by":"publisher","first-page":"486","DOI":"10.1189\/jlb.0303101","volume":"74","author":"TW Klein","year":"2003","unstructured":"Klein, T.W. et al. The cannabinoid system and immune modulation. J. Leukoc. Biol. 74, 486\u2013496 (2003).","journal-title":"J. Leukoc. Biol."},{"key":"BFnm1561_CR7","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1126\/science.1115740","volume":"310","author":"MD Van Sickle","year":"2005","unstructured":"Van Sickle, M.D. et al. Identification and functional characterization of brainstem cannabinoid CB2 receptors. Science 310, 329\u2013332 (2005).","journal-title":"Science"},{"key":"BFnm1561_CR8","doi-asserted-by":"publisher","first-page":"4917","DOI":"10.1046\/j.1432-1327.2000.01550.x","volume":"267","author":"M Salzet","year":"2000","unstructured":"Salzet, M., Breton, C., Bisogno, T. & Di Marzo, V. Comparative biology of the endocannabinoid system possible role in the immune response. Eur. J. Biochem. 267, 4917\u20134927 (2000).","journal-title":"Eur. J. Biochem."},{"key":"BFnm1561_CR9","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1016\/S0163-7258(02)00255-3","volume":"95","author":"RG Pertwee","year":"2002","unstructured":"Pertwee, R.G. Cannabinoids and multiple sclerosis. Pharmacol. Ther. 95, 165\u2013174 (2002).","journal-title":"Pharmacol. Ther."},{"key":"BFnm1561_CR10","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1016\/0165-5728(89)90075-1","volume":"23","author":"WD Lyman","year":"1989","unstructured":"Lyman, W.D., Sonett, J.R., Brosnan, C.F., Elkin, R. & Bornstein, M.B. \u03949-tetrahydrocannabinol: a novel treatment for experimental autoimmune encephalomyelitis. J. Neuroimmunol. 23, 73\u201381 (1989).","journal-title":"J. Neuroimmunol."},{"key":"BFnm1561_CR11","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1016\/0162-3109(94)90056-6","volume":"28","author":"I Wirguin","year":"1994","unstructured":"Wirguin, I. et al. Suppression of experimental autoimmune encephalomyelitis by cannabinoids. Immunopharmacology 28, 209\u2013214 (1994).","journal-title":"Immunopharmacology"},{"key":"BFnm1561_CR12","doi-asserted-by":"publisher","first-page":"2511","DOI":"10.1523\/JNEUROSCI.23-07-02511.2003","volume":"23","author":"A Ar\u00e9valo-Mart\u00edn","year":"2003","unstructured":"Ar\u00e9valo-Mart\u00edn, A., Vela, J.M., Molina-Holgado, E., Borrell, J. & Guaza, C. Therapeutic action of cannabinoids in a murine model of multiple sclerosis. J. Neurosci. 23, 2511\u20132516 (2003).","journal-title":"J. Neurosci."},{"key":"BFnm1561_CR13","doi-asserted-by":"publisher","first-page":"2191","DOI":"10.1093\/brain\/awg224","volume":"126","author":"G Pryce","year":"2003","unstructured":"Pryce, G. et al. Cannabinoids inhibit neurodegeneration in models of multiple sclerosis. Brain 126, 2191\u20132202 (2003).","journal-title":"Brain"},{"key":"BFnm1561_CR14","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1016\/S0022-3565(24)37266-0","volume":"284","author":"M Rinaldi-Carmona","year":"1998","unstructured":"Rinaldi-Carmona, M. et al. SR 144528, the first potent and selective antagonist of the CB2 cannabinoid receptor. J. Pharmacol. Exp. Ther. 284, 644\u2013650 (1998).","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"BFnm1561_CR15","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1016\/0014-5793(94)00773-X","volume":"350","author":"M Rinaldi-Carmona","year":"1994","unstructured":"Rinaldi-Carmona, M. et al. SR141716A, a potent and selective antagonist of the brain cannabinoid receptor. FEBS Lett. 350, 240\u2013244 (1994).","journal-title":"FEBS Lett."},{"key":"BFnm1561_CR16","doi-asserted-by":"publisher","first-page":"2373","DOI":"10.4049\/jimmunol.173.4.2373","volume":"173","author":"Y Do","year":"2004","unstructured":"Do, Y., McKallip, R.J., Nagarkatti, M. & Nagarkatti, P.S. Activation through cannabinoid receptors 1 and 2 on dendritic cells triggers NF-\u03baB-dependent apoptosis: novel role for endogenous and exogenous cannabinoids in immunoregulation. J. Immunol. 173, 2373\u20132382 (2004).","journal-title":"J. Immunol."},{"key":"BFnm1561_CR17","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1054\/plef.2001.0355","volume":"66","author":"D Parolaro","year":"2002","unstructured":"Parolaro, D., Massi, P., Rubino, T. & Monti, E. Endocannabinoids in the immune system and cancer. Prostaglandins Leukot. Essent. Fatty Acids 66, 319\u2013332 (2002).","journal-title":"Prostaglandins Leukot. Essent. Fatty Acids"},{"key":"BFnm1561_CR18","doi-asserted-by":"publisher","first-page":"1587","DOI":"10.4049\/jimmunol.173.3.1587","volume":"173","author":"ED Ponomarev","year":"2004","unstructured":"Ponomarev, E.D. et al. \u03b3\u03b4 T cell regulation of IFN-\u03b3 production by central nervous system-infiltrating encephalitogenic T cells: correlation with recovery from experimental autoimmune encephalomyelitis. J. Immunol. 173, 1587\u20131595 (2004).","journal-title":"J. Immunol."},{"key":"BFnm1561_CR19","doi-asserted-by":"publisher","first-page":"39","DOI":"10.4049\/jimmunol.178.1.39","volume":"178","author":"ED Ponomarev","year":"2007","unstructured":"Ponomarev, E.D. et al. GM-CSF production by autoreactive T cells is required for the activation of microglial cells and the onset of experimental autoimmune encephalomyelitis. J. Immunol. 178, 39\u201348 (2007).","journal-title":"J. Immunol."},{"key":"BFnm1561_CR20","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1016\/S0009-3084(00)00189-4","volume":"108","author":"T Sugiura","year":"2000","unstructured":"Sugiura, T. & Waku, K. 2-Arachidonoylglycerol and the cannabinoid receptors. Chem. Phys. Lipids 108, 89\u2013106 (2000).","journal-title":"Chem. Phys. Lipids"},{"key":"BFnm1561_CR21","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1111\/j.1471-4159.2005.03380.x","volume":"95","author":"K Maresz","year":"2005","unstructured":"Maresz, K., Carrier, E.J., Ponomarev, E.D., Hillard, C.J. & Dittel, B.N. Modulation of the cannabinoid CB2 receptor in microglial cells in response to inflammatory stimuli. J. Neurochem. 95, 437\u2013445 (2005).","journal-title":"J. Neurochem."},{"key":"BFnm1561_CR22","doi-asserted-by":"publisher","first-page":"3214","DOI":"10.1073\/pnas.0306707101","volume":"101","author":"A Witting","year":"2004","unstructured":"Witting, A., Walter, L., Wacker, J., Moller, T. & Stella, N. P2X7 receptors control 2-arachidonoylglycerol production by microglial cells. Proc. Natl. Acad. Sci. USA 101, 3214\u20133219 (2004).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"BFnm1561_CR23","doi-asserted-by":"publisher","first-page":"6362","DOI":"10.1073\/pnas.0510418103","volume":"103","author":"A Witting","year":"2006","unstructured":"Witting, A. et al. Experimental autoimmune encephalomyelitis disrupts endocannabinoid-mediated neuroprotection. Proc. Natl. Acad. Sci. USA 103, 6362\u20136367 (2006).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"BFnm1561_CR24","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1126\/science.1088208","volume":"302","author":"G Marsicano","year":"2003","unstructured":"Marsicano, G. et al. CB1 cannabinoid receptors and on-demand defense against excitotoxicity. Science 302, 84\u201388 (2003).","journal-title":"Science"},{"key":"BFnm1561_CR25","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1038\/12703","volume":"23","author":"F Tronche","year":"1999","unstructured":"Tronche, F. et al. Disruption of the glucocorticoid receptor gene in the nervous system results in reduced anxiety. Nat. Genet. 23, 99\u2013103 (1999).","journal-title":"Nat. Genet."},{"key":"BFnm1561_CR26","doi-asserted-by":"publisher","first-page":"12070","DOI":"10.1073\/pnas.92.26.12070","volume":"92","author":"T Hennet","year":"1995","unstructured":"Hennet, T., Hagen, F.K., Tabak, L.A. & Marth, J.D. T-cell-specific deletion of a polypeptide N-acetylgalactosaminyl-transferase gene by site-directed recombination. Proc. Natl. Acad. Sci. USA 92, 12070\u201312074 (1995).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"BFnm1561_CR27","doi-asserted-by":"crossref","first-page":"6392","DOI":"10.4049\/jimmunol.162.11.6392","volume":"162","author":"BN Dittel","year":"1999","unstructured":"Dittel, B.N., Merchant, R.M. & Janeway, C.A., Jr Evidence for Fas-dependent and Fas-independent mechanisms in the pathogenesis of experimental autoimmune encephalomyelitis. J. Immunol. 162, 6392\u20136400 (1999).","journal-title":"J. Immunol."},{"key":"BFnm1561_CR28","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1016\/S0014-2999(00)00211-9","volume":"396","author":"NE Buckley","year":"2000","unstructured":"Buckley, N.E. et al. Immunomodulation by cannabinoids is absent in mice deficient for the cannabinoid CB2 receptor. Eur. J. Pharmacol. 396, 141\u2013149 (2000).","journal-title":"Eur. J. Pharmacol."},{"key":"BFnm1561_CR29","doi-asserted-by":"publisher","first-page":"4678","DOI":"10.4049\/jimmunol.174.8.4678","volume":"174","author":"ED Ponomarev","year":"2005","unstructured":"Ponomarev, E.D. & Dittel, B.N. \u03b3\u03b4 T cells regulate the extent and duration of inflammation in the central nervous system by a Fas ligand-dependent mechanism. J. Immunol. 174, 4678\u20134687 (2005).","journal-title":"J. Immunol."},{"key":"BFnm1561_CR30","doi-asserted-by":"publisher","first-page":"2905","DOI":"10.1016\/S0968-0896(99)00219-9","volume":"7","author":"JW Huffman","year":"1999","unstructured":"Huffman, J.W. et al. 3-(1\u2032,1\u2032-Dimethylbutyl)-1-deoxy-delta8-THC and related compounds: synthesis of selective ligands for the CB2 receptor. Bioorg. Med. Chem. 7, 2905\u20132914 (1999).","journal-title":"Bioorg. Med. Chem."}],"container-title":["Nature Medicine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/nm1561.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/nm1561","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/nm1561.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,15]],"date-time":"2025-01-15T10:37:27Z","timestamp":1736937447000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/nm1561"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,4]]},"references-count":30,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2007,4]]}},"alternative-id":["BFnm1561"],"URL":"https:\/\/doi.org\/10.1038\/nm1561","relation":{},"ISSN":["1078-8956","1546-170X"],"issn-type":[{"value":"1078-8956","type":"print"},{"value":"1546-170X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2007,4]]}}}